<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>For 20 years, the clinical, genetic and therapeutic knowledge of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> made great progress </plain></SENT>
<SENT sid="1" pm="."><plain>The new classification, allowing the diagnosis and published in 2010, is easier to use </plain></SENT>
<SENT sid="2" pm="."><plain>The diagnosis remains sometimes difficult particularly during childhood, because of the great variability of expression of the disease, from neonatal <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, to a weak clinical expression and especially because of the evolution of the signs with the age, which no classification takes into account </plain></SENT>
<SENT sid="3" pm="."><plain>The search for amutation in the FBN1 gene is long and expensive and must be reserved only for patients having a very strong diagnostic suspicion </plain></SENT>
<SENT sid="4" pm="."><plain>The therapeutics is preventive and based on patient education, limitation of the sport, beta blockade therapy, regular echocardiography as well as aorta replacement </plain></SENT>
<SENT sid="5" pm="."><plain>New treatments are at present on approval but did not make the proof of their efficiency </plain></SENT>
<SENT sid="6" pm="."><plain>The global care of the patient, by taking into account difficulties about genetic origin of the disease, aesthetic and psychological consequences, allows an improvement of the quality of life </plain></SENT>
</text></document>